However, no significant difference in age at diagnosis was found between glioma patients with MGMT-methylated and MGMT-unmethylated (48.30 ± 11.40 vs. 44.96 ± 16.71, P = 0.517). The gene discussed is MGMT; the disease is central nervous system cancer.